Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of May 21, 2026, TNGX trades at $20.87 with a market cap of $2.98B and a P/E ratio of -24.47. TNGX moved +3.69% today. Year to date, TNGX is +136.59%; over the trailing twelve months it is +918.36%. Its 52-week range spans $1.03 to $28.41. Analyst consensus is strong buy with an average price target of $30.70. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TNGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TNGX recently traded at $20.87. Market cap is $2.98B. P/E ratio is -24.47. Revenue is $62.38M.
| Metric | Value |
|---|---|
| Price | $20.87 |
| Market Cap | $2.98B |
| P/E Ratio | -24.47 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.41 |
| 52-Week Low | $1.03 |
| Volume | 45 |
| Avg Volume | 0 |
| Revenue (TTM) | $62.38M |
| Net Income | $-101.59M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $62.38M | $-101.59M | $-0.87 |
| 2024 | $42.07M | $-130.30M | $-1.19 |
| 2023 | $36.53M | $-101.74M | $-1.08 |
| 2022 | $24.86M | $-108.18M | $-1.23 |
10 analysts cover TNGX: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.70.